Does BROMAZEPAM Cause Disseminated intravascular coagulation? 8 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Disseminated intravascular coagulation have been filed in association with BROMAZEPAM. This represents 0.1% of all adverse event reports for BROMAZEPAM.
8
Reports of Disseminated intravascular coagulation with BROMAZEPAM
0.1%
of all BROMAZEPAM reports
2
Deaths
3
Hospitalizations
How Dangerous Is Disseminated intravascular coagulation From BROMAZEPAM?
Of the 8 reports, 2 (25.0%) resulted in death, 3 (37.5%) required hospitalization, and 5 (62.5%) were considered life-threatening.
Is Disseminated intravascular coagulation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BROMAZEPAM. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does BROMAZEPAM Cause?
Drug abuse (964)
Toxicity to various agents (914)
Coma (790)
Somnolence (641)
Intentional overdose (467)
Poisoning deliberate (419)
Fall (385)
Hypotension (375)
Drug use disorder (351)
Suicide attempt (345)
What Other Drugs Cause Disseminated intravascular coagulation?
PREDNISOLONE (362)
METHOTREXATE (347)
DEXAMETHASONE (323)
METHYLPREDNISOLONE (307)
NIVOLUMAB (305)
CYCLOPHOSPHAMIDE (286)
TACROLIMUS (278)
PREDNISONE (277)
VINCRISTINE (245)
OXALIPLATIN (231)
Which BROMAZEPAM Alternatives Have Lower Disseminated intravascular coagulation Risk?
BROMAZEPAM vs BROMFENAC
BROMAZEPAM vs BROMHEXINE
BROMAZEPAM vs BROMOCRIPTINE
BROMAZEPAM vs BROTIZOLAM
BROMAZEPAM vs BUCILLAMINE